Position in BCAX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$47,579,863
+$10,475,604 QoQ
Shares Held
2,392,150
+8.5% QoQ
Ownership
3.64%
of shares outstanding
% of Portfolio
29.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BCAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Omega Fund Management, LLC holds $129,582,182 across 8 Biotechnology names. BCAX ranks #1 (36.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BCAX |
Bicara Therapeutics Inc.
This page
|
2,392,150 | $47,579,863 | |
| 2 | NUVB |
Nuvation Bio Inc.
|
8,081,089 | $34,667,871 | |
| 3 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
3,289,661 | $29,442,465 | |
| 4 | ENGN |
enGene Therapeutics Inc.
|
876,357 | $5,967,991 | |
| 5 | ALMS |
Alumis Inc.
|
241,255 | $5,314,847 | |
| 6 | SANA |
Sana Biotechnology, Inc.
|
843,750 | $2,430,000 | |
| 7 | IMA |
ImageneBio, Inc.
|
455,361 | $2,276,805 | |
| 8 | REPL |
Replimune Group, Inc.
|
248,672 | $1,902,340 |
All Filings in BCAX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $47,579,863 | 2,392,150 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $37,104,259 | 2,204,650 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $34,811,423 | 2,204,650 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $20,481,198 | 2,204,650 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $28,726,589 | 2,204,650 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $38,405,003 | 2,204,650 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $56,152,435 | 2,204,650 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||